blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3508484

EP3508484 - HETEROCYCLIC AMIDES AS KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.02.2022
Database last updated on 15.06.2024
FormerThe patent has been granted
Status updated on  05.03.2021
FormerGrant of patent is intended
Status updated on  10.11.2020
FormerRequest for examination was made
Status updated on  25.09.2020
FormerGrant of patent is intended
Status updated on  22.09.2020
FormerRequest for examination was made
Status updated on  02.09.2020
FormerGrant of patent is intended
Status updated on  13.08.2020
FormerRequest for examination was made
Status updated on  07.06.2019
Most recent event   Tooltip03.05.2024Lapse of the patent in a contracting state
New state(s): MK
published on 05.06.2024  [2024/23]
Applicant(s)For all designated states
GlaxoSmithKline Intellectual Property Development Limited
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2019/28]
Inventor(s)01 / BANDYOPADHYAY, Deepak
1250 South Collegeville Road
Collegeville, PA 19426 / US
02 / EIDAM, Patrick M.
1250 South Collegeville Road
Collegeville, PA 19426 / US
03 / GOUGH, Peter J.
1250 South Collegeville Road
Collegeville, PA 19426 / US
04 / HARRIS, Philip Anthony
1250 South Collegeville Road
Collegeville, PA 19426 / US
05 / JEONG, Jae U.
1250 South Collegeville Road
Collegeville, PA 19426 / US
06 / KANG, Jianxing
1250 South Collegeville Road
Collegeville, PA 19426 / US
07 / KING, Bryan Wayne
1250 South Collegeville Road
Collegeville, PA 19426 / US
08 / LAKDAWALA SHAH, Ami
709 Swedeland Road
King of Prussia, PA 19406 / US
09 / MARQUIS, JR., Robert W.
1250 South Collegeville Road
Collegeville, PA 19426 / US
10 / LEISTER, Lara Kathryn
1250 South Collegeville Road
Collegeville, PA 19426 / US
11 / RAHMAN, Attiq
1250 South Collegeville Road
Collegeville, PA 19426 / US
12 / RAMANJULU, Joshi M.
1250 South Collegeville Road
Collegeville, PA 19426 / US
13 / SEHON, Clark A.
1250 South Collegeville Road
Collegeville, PA 19426 / US
14 / SINGHAUS, JR., Robert
1250 South Collegeville Road
Collegeville, PA 19426 / US
15 / ZHANG, Daohua
1250 South Collegeville Road
Collegeville, PA 19426 / US
 [2019/28]
Representative(s)Knight, Lucie Viktoria, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2019/28]Price, Susanna Clare Hopley
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date19154374.314.02.2014
[2019/28]
Priority number, dateUS201361765664P15.02.2013         Original published format: US 201361765664 P
US201361790044P15.03.2013         Original published format: US 201361790044 P
[2019/28]
Previously filed application, dateEP2018015583614.02.2014
[2019/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3508484
Date:10.07.2019
Language:EN
[2019/28]
Type: B1 Patent specification 
No.:EP3508484
Date:07.04.2021
Language:EN
[2021/14]
Search report(s)(Supplementary) European search report - dispatched on:EP25.04.2019
ClassificationIPC:C07D403/12, C07D413/14, C07D403/14, C07D409/12, C07D413/12, C07D417/12, C07D487/04, C07D267/14, C07D498/04, C07D281/10, A61P37/00, A61P25/28, A61P17/06, A61P29/00, A61K31/55, A61K31/5513, A61K31/553, A61K31/554, C07D223/08
[2019/28]
CPC:
A61K31/553 (EP,KR,US); C07D417/12 (EP,EA,KR,US); C07D403/12 (EP,CN,EA,KR,US);
A61K31/55 (EP,EA,US); A61K31/551 (US); A61P1/00 (EP);
A61P1/02 (EP); A61P1/04 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P11/08 (EP); A61P13/12 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/04 (EP); A61P17/06 (EP,EA);
A61P19/02 (EP); A61P19/04 (EP); A61P19/06 (EP);
A61P19/08 (EP); A61P21/00 (EP); A61P25/00 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/28 (EP,EA);
A61P27/00 (EP); A61P27/02 (EP); A61P29/00 (EP,EA);
A61P29/02 (EP); A61P3/00 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P31/04 (EP); A61P31/06 (EP);
A61P31/12 (EP); A61P31/14 (EP); A61P31/16 (EP);
A61P35/00 (EP); A61P37/00 (EP,EA); A61P37/02 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/10 (EP); C07D223/08 (EP,US);
C07D267/14 (EP,EA,KR,US); C07D281/10 (EP,EA,KR,US); C07D403/14 (EP,CN,EA,US);
C07D409/12 (EP,CN,EA,US); C07D413/12 (EP,CN,EA,KR,US); C07D413/14 (EP,CN,EA,KR,US);
C07D487/04 (EP,EA,KR,US); C07D498/04 (EP,EA,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/28]
Extension statesBA30.01.2019
ME30.01.2019
TitleGerman:HETEROZYCLISCHE AMIDE ALS KINASE INHIBITOREN[2019/28]
English:HETEROCYCLIC AMIDES AS KINASE INHIBITORS[2019/28]
French:AMIDES HÉTÉROCYCLIQUES EN TANT QU'INHIBITEURS DE LA KINASE[2019/28]
Examination procedure30.01.2019Examination requested  [2019/28]
11.02.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
13.02.2020Amendment by applicant (claims and/or description)
11.11.2020Communication of intention to grant the patent
23.02.2021Fee for grant paid
23.02.2021Fee for publishing/printing paid
23.02.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14705891.1  / EP2956452
EP18155836.2  / EP3342771
Opposition(s)10.01.2022No opposition filed within time limit [2022/11]
Request for further processing for:The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
13.02.2020Request for further processing filed
13.02.2020Full payment received (date of receipt of payment)
Request granted
11.03.2020Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
13.02.2020Request for further processing filed
13.02.2020Full payment received (date of receipt of payment)
Request granted
11.03.2020Decision despatched
Fees paidRenewal fee
30.01.2019Renewal fee patent year 03
30.01.2019Renewal fee patent year 04
30.01.2019Renewal fee patent year 05
30.01.2019Renewal fee patent year 06
10.02.2020Renewal fee patent year 07
09.02.2021Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.02.2014
AL07.04.2021
AT07.04.2021
CY07.04.2021
CZ07.04.2021
DK07.04.2021
EE07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
IT07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
MK07.04.2021
NL07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SE07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
[2024/23]
Former [2024/20]HU14.02.2014
AL07.04.2021
AT07.04.2021
CY07.04.2021
CZ07.04.2021
DK07.04.2021
EE07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
IT07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
NL07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SE07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2024/18]HU14.02.2014
AL07.04.2021
AT07.04.2021
CZ07.04.2021
DK07.04.2021
EE07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
IT07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
NL07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SE07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/44]AL07.04.2021
AT07.04.2021
CZ07.04.2021
DK07.04.2021
EE07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
IT07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
NL07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SE07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/36]AL07.04.2021
AT07.04.2021
CZ07.04.2021
DK07.04.2021
EE07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
IT07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SE07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/29]AL07.04.2021
AT07.04.2021
CZ07.04.2021
DK07.04.2021
EE07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SE07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/26]AL07.04.2021
AT07.04.2021
CZ07.04.2021
DK07.04.2021
EE07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SE07.04.2021
SK07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/23]AT07.04.2021
CZ07.04.2021
DK07.04.2021
EE07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SE07.04.2021
SK07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/10]AT07.04.2021
CZ07.04.2021
DK07.04.2021
EE07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SE07.04.2021
SK07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
PT09.08.2021
IS22.12.2021
Former [2022/09]AT07.04.2021
CZ07.04.2021
DK07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SE07.04.2021
SK07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/08]AT07.04.2021
CZ07.04.2021
DK07.04.2021
ES07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
PL07.04.2021
RS07.04.2021
SE07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/07]AT07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
PL07.04.2021
RS07.04.2021
SE07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2021/52]AT07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
PL07.04.2021
RS07.04.2021
SE07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2021/51]AT07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
RS07.04.2021
SE07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2021/50]AT07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
SE07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
PT09.08.2021
Former [2021/49]AT07.04.2021
FI07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
NL07.04.2021
SE07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
Former [2021/46]AT07.04.2021
FI07.04.2021
LT07.04.2021
NL07.04.2021
BG07.07.2021
Documents cited:Search[A]WO2004098589  (ELAN PHARM INC [US], et al) [A] 1-19* claims 1, 21-25 *;
 [A]WO2007075772  (HARVARD COLLEGE [US], et al) [A] 1-19 * table 1 * * claim 1 * * page 91, line 1 - line 2 * * example 10 *
by applicantWO2008106077
    - Trends Biochem. Sci., (20050000), vol. 30, pages 151 - 159
    - Cell, (19950000), vol. 81, pages 513 - 523
    - Immunity, (19970000), vol. 7, pages 821 - 830
    - Immunity, (19960000), vol. 4, pages 387 - 396
    - Nat Immunol., (20040000), vol. 5, pages 503 - 507
    - EMBO Rep., (20090000), vol. 10, pages 916 - 922
    - J. Biol. Chem., (19990000), vol. 274, pages 16871 - 16875
    - Curr. Biol., (19990000), vol. 9, pages 539 - 542
    - J. Biol. Chem., (20050000), vol. 280, pages 36560 - 36566
    - J. Biol. Chem., (20040000), vol. 279, pages 7925 - 7933
    - Cell, (20030000), vol. 114, pages 181 - 190
    - Mol. Cell, (20060000), vol. 22, pages 245 - 257
    - J. Mol. Biol., (20100000), vol. 396, pages 528 - 539
    - Nat. Immunol., (20080000), vol. 9, pages 1037 - 1046
    - Proc. Natl. Acad. Sci. USA., (20080000), vol. 105, pages 11778 - 11783
    - Sci. Signal., (20100000), vol. 115, page re4
    - Cell Death Dis., (20110000), vol. 2, page 2 el 15
    - FEBS J, (20120000), vol. 278, pages 877 - 887
    - Cell, (20120000), vol. 148, pages 228 - 243
    - Proc. Natl. Acad. Sci. USA., (20120000), vol. 109, pages 5322 - 5327
    - Nat. Rev. Immunol, (20080000), vol. 8, pages 279 - 289
    - Nature, (20110000), vol. 477, pages 330 - 334
    - DUPREZ, L. et al., Immunity, (20110000), vol. 35, no. 6, pages 908 - 918
    - PNAS, (20100000), vol. 107, pages 21695 - 21700
    - Proc. Natl. Acad. Sci., (20120000), vol. 109, no. 36, pages 14598 - 14603
    - HE, S. et al., Cell, (20090000), vol. 137, no. 6, pages 1 100 - 1111
    - Nat. Chem. Biol., (20050000), vol. 1, pages 112 - 119
    - J. Neurosci. Res., (20100000), vol. 88, pages 1569 - 1576
    - Kidney Int., (20120000), vol. 81, pages 751 - 761
    - Ren. Fail., (20120000), vol. 34, pages 373 - 377
    - Neurochem. Res., (20120000), vol. 37, pages 1849 - 1858
    - Genes Dev., (20130000), vol. 27, pages 1640 - 1649
    - Cell Host & Microbe, (20140000), vol. 15, pages 23 - 35
    - Cell, (20130000), vol. 153, pages 1 - 14
    - ELEMES, Y.RAGNARSSON, U., J. Chern. Soc., Perkin Trans., (19960000), vol. 1, no. 6, pages 537 - 40
    - ARMSTRONG, Tetrahedron Letters, (19940000), pages 3239 - 42
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.